BioCentury
ARTICLE | Company News

Merck, Kyorin deal

January 12, 2015 8:00 AM UTC

Merck’s MSD K.K. subsidiary granted Kyorin co-marketing and co-promotion rights in Japan to desloratadine. The second-generation histamine H1 receptor antagonist is in Phase III testing to treat alle...